Tokyo Tape
Sign in
← Falco Holdings

Quarterly report · Q2

4671.TEDINET S100S7JG
Period2023-04-01 → 2023-09-30
Filed2023-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥21.3bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥46.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥24.2bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥851m2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.7bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥931m2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.9bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.1bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.9bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥629m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.3bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥1.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥629m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥1.1bn2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥36.7bnat 2023-09-30Cons.Assets
Total assets¥38.9bnat 2023-03-31Cons.Assets
Total assets¥38.7bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥10.7bnat 2023-09-30Cons.Liabilities
Total liabilities¥12.3bnat 2023-03-31Cons.Liabilities
Net assets / equity¥26.0bnat 2023-09-30Cons.Net assets
Net assets / equity¥26.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥24.3bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥9.2bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥12.6bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥9.2bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥12.6bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥10.9bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥10.6bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥1.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥2.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.9bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow¥322m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥249m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.2bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥448m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥937m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥56.292023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥45.342023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥215.292022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥107.52022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥65.162022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥56.142023-04-01 → 2023-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥214.032022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥107.182022-04-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
Equity ratio70.6%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio68.2%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.6%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30¥0
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30¥0
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥270m
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥13.0bn
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥689m
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥7.9bn
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥7.9bn
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥0
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥385m
jpcrp040300-q2r_E04982-000ICT Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥449m
jpcrp040300-q2r_E04982-000ICT Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥449m
jpcrp040300-q2r_E04982-000ICT Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥46m
—segment totalrevenue2023-04-01 → 2023-09-30¥21.3bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥21.3bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥0
—segment totalsegment profit2023-04-01 → 2023-09-30¥1.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥4m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥4m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥213m
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥15.9bn
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥15.9bn
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4m
jpcrp040300-q2r_E04982-000Clinical Testing Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥1.7bn
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥0
jpcrp040300-q2r_E04982-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥320m
jpcrp040300-q2r_E04982-000ICT Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥293m
jpcrp040300-q2r_E04982-000ICT Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥293m
jpcrp040300-q2r_E04982-000ICT Businessreportable segmentsegment profit2022-04-01 → 2022-09-30−¥99m
—segment totalrevenue2022-04-01 → 2022-09-30¥24.2bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥24.2bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥4m
—segment totalsegment profit2022-04-01 → 2022-09-30¥2.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 539
ItemContextValueUnit
Raw materials and suppliesPrior1YearInstant556000000JPY
Raw materials and suppliesCurrentQuarterInstant502000000JPY
Other caPrior1YearInstant1996000000JPY
Other caCurrentQuarterInstant2083000000JPY
Allowance for doubtful accounts caPrior1YearInstant-1000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-0JPY
Current assetsPrior1YearInstant22706000000JPY
Current assetsCurrentQuarterInstant19109000000JPY
Buildings and structuresPrior1YearInstant9435000000JPY
Buildings and structuresCurrentQuarterInstant9331000000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-4761000000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-4761000000JPY
Buildings and structures netPrior1YearInstant4674000000JPY
Buildings and structures netCurrentQuarterInstant4570000000JPY
LandPrior1YearInstant4924000000JPY
LandCurrentQuarterInstant5373000000JPY
Lease assets ppePrior1YearInstant1290000000JPY
Lease assets ppeCurrentQuarterInstant1253000000JPY
Accumulated depreciation lease assets ppePrior1YearInstant-906000000JPY
Accumulated depreciation lease assets ppeCurrentQuarterInstant-992000000JPY
Lease assets net ppePrior1YearInstant383000000JPY
Lease assets net ppeCurrentQuarterInstant260000000JPY
Other ppePrior1YearInstant4395000000JPY
Other ppeCurrentQuarterInstant4429000000JPY
Accumulated depreciation other ppePrior1YearInstant-3655000000JPY
Accumulated depreciation other ppeCurrentQuarterInstant-3716000000JPY
Other net ppePrior1YearInstant739000000JPY
Other net ppeCurrentQuarterInstant712000000JPY
Property plant and equipmentPrior1YearInstant10722000000JPY
Property plant and equipmentCurrentQuarterInstant10916000000JPY
GoodwillPrior1YearInstant12000000JPY
GoodwillCurrentQuarterInstant4000000JPY
Other iaPrior1YearInstant365000000JPY
Other iaCurrentQuarterInstant330000000JPY
Intangible assetsPrior1YearInstant378000000JPY
Intangible assetsCurrentQuarterInstant335000000JPY
Investment securitiesPrior1YearInstant2618000000JPY
Investment securitiesCurrentQuarterInstant4057000000JPY
Other ioaPrior1YearInstant2471000000JPY
Other ioaCurrentQuarterInstant2331000000JPY
Allowance for doubtful accounts ioa by groupPrior1YearInstant-5000000JPY
Allowance for doubtful accounts ioa by groupCurrentQuarterInstant-4000000JPY
Investments and other assetsPrior1YearInstant5085000000JPY
Investments and other assetsCurrentQuarterInstant6384000000JPY
Noncurrent assetsPrior1YearInstant16187000000JPY
Noncurrent assetsCurrentQuarterInstant17636000000JPY
AssetsPrior1YearInstant38893000000JPY
AssetsCurrentQuarterInstant36746000000JPY
Notes and accounts payable tradePrior1YearInstant4374000000JPY
Notes and accounts payable tradeCurrentQuarterInstant4493000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass